ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

SurModics Expands Protein-Free Stabilizer Line with AP Option

Print | 
Email |  Comment   Share  

SurModics, Inc.
9924 W. 74th St, MS-1194
Eden Prairie, MN, 55344

Press release date: July 28, 2014

AACC Annual Meeting and Clinical Lab Expo 2014

EDEN PRAIRIE, Minn.-- SurModics IVD, Inc., a wholly owned subsidiary of SurModics, Inc. (NASDAQ:SRDX) and a market leader for in vitro diagnostic assay components, is introducing StabilZymeŽ Protein-Free AP Stabilizer at the American Association for Clinical Chemistry meeting currently taking place in Chicago.

“Protein interference is a frequent concern, particularly as more sensitive assays are developed,” says Drew Pauly, Director of Product Development, SurModics IVD. “Proteins used in many stabilizers can lead to increased non-specific binding due to protein interference. There is a need for a protein-free stabilizer for alkaline phosphatase conjugates that delivers equivalent performance to protein-containing stabilizers, including those with BSA (bovine serum albumin). This new StabilZyme protein-free stabilizer achieves that goal.”

The new stabilizer eliminates protein-related interference and cross-reactivity. It also offers excellent performance. The retained activity of StabilZyme Protein-Free AP Stabilizer is comparable to its protein-containing counterpart—StabilZyme AP Conjugate Stabilizer—and superior to other protein-free/BSA-free stabilizers on the market. It performs across all species of antibodies, even at low concentrations.

AACC attendees can learn more by visiting the SurModics IVD Booth #1938. AACC is the world’s largest laboratory medicine exposition, with 20,000 attendees.

SurModics IVD offers a full range of innovative solutions, including custom formulations, for the in vitro diagnostics industry. To learn more, visit our website (, or contact customer service (952-500-7200 or More than 900 IVD products are available for online ordering at

About SurModics, Inc.
SurModics' mission is to exceed our customers' expectations and enhance the wellbeing of patients by providing the world's foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world's leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include (i) surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities, and (ii) components for in vitro diagnostic tests and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit The content of SurModics' website is not part of this release or part of any filings the Company makes with the SEC.

SurModics and StabilZyme are registered trademarks of SurModics, Inc. and/or its affiliates.
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


Post a comment about this story

(your e-mail address will not be posted)
Comment title:
To submit comment, enter the security code shown below and press 'Post Comment'.

 See related product stories
More .....
 See more product news in:
Mechanical Components and Assemblies
 More New Product News from this company:
TMB Stop Solution is non-corrosive and non-hazardous.
Immunodiagnostic Reagent offers 2-year stability.
More ....
| Featured Manufacturing Jobs
 Other News from this company:
SurModics IVD Breakthrough Stabilizer Addresses Industry Challenge
SurModics' New Low Friction, Low Particulate Device Coatings Introduced
SurModics to Webcast Second Quarter Fiscal Year 2011 Earnings Conference Call April 27
SurModics to Webcast Fiscal 2008 First Quarter Earnings Conference
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of

Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy

Error close

Please enter a valid email address